This paper describes and analyzes B. F. Skinner's coauthoring practices. After identifying his 35 coauthored publications and 27 coauthors, we analyze his coauthored works by their form (e.g., journal articles) and kind (e.g., empirical); identify the journals in which he published and their type (e.g., data-type); describe his overall and local rates of publishing with his coauthors (e.g., noting breaks in the latter); and compare his coauthoring practices with his single-authoring practices (e.g., form, kind, journal type) and with those in the scientometric literature (e.g., majority of coauthored publications are empirical). We address these findings in the context of describing the natural history of Skinner's coauthoring practices. Finally, we describe some limitations in our methods and offer suggestions for future research.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089415 | PMC |
| http://dx.doi.org/10.1007/BF03392236 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Two meningococcal serogroup B vaccines are licensed for use in the United States. In August 2024, the Food and Drug Administration (FDA) changed the label for the meningococcal serogroup B MenB-4C vaccine (Bexsero) from a 2-dose schedule (intervals of 0 and ≥1 month) to a 2-dose schedule (0 and 6 months) and added a 3-dose schedule (0, 1-2, and 6 months), based on new immunogenicity data. On October 24, 2024, the Advisory Committee on Immunization Practices (ACIP) voted to update its recommendations for the MenB-4C dosing interval and schedule to align with the new FDA label.
View Article and Find Full Text PDFCo-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with Dementia.
Drugs Aging
October 2024
Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Background And Objective: As dementia progresses, people living with dementia may take high-risk, unnecessary, or ineffective medicines. Cholinesterase inhibitors (ChEIs) may have benefit in some people with dementia; however, up to one third are continued when no longer necessary or safe. Our aim was to co-design a consult patient decision aid (CPtDA) to support shared decision making between healthcare professionals and consumers about continuing or deprescribing ChEIs.
View Article and Find Full Text PDFMedical Evaluation for Respirator Use-Updated Approaches.
J Occup Environ Med
October 2024
From the Environmental Health Sciences, University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson, Arizona (P.H.); and Mount Auburn Hospital (emeritus status), Cambridge, Massachusetts (W.S.B.).
Objective: Respirator medical evaluations are an important component of occupational health practice. Concepts and practices were established 25-50 years ago.
Method: We suggest analysis and discussion of three areas warranting update.
High certainty evidence is stable and trustworthy, whereas evidence of moderate or lower certainty may be equally prone to being unstable.
J Clin Epidemiol
July 2024
Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA; Department of Clinical Research, University of Basel, University Hospital Basel, Basel, Switzerland; Pragmatic Evidence Lab, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland; Meta-Research Innovation Center Berlin (METRIC-B), Berlin Institute of Health, Berlin, Germany.
Objectives: To assess to what extent the overall quality of evidence indicates changes to observe intervention effect estimates when new data become available.
Methods: We conducted a meta-epidemiological study. We obtained evidence from meta-analyses of randomized trials of Cochrane reviews addressing the same health-care question that was updated with inclusion of additional data between January 2016 and May 2021.
Leveraging a realistic synthetic database to learn Shape-from-Shading for estimating the colon depth in colonoscopy images.
Comput Med Imaging Graph
July 2024
Unité d'Informatique et d'Ingénierie des Systémes (U2IS), ENSTA Paris, Institut Polytechnique de Paris, Palaiseau, 91762, Ile de France, France.
Colonoscopy is the choice procedure to diagnose, screening, and treat the colon and rectum cancer, from early detection of small precancerous lesions (polyps), to confirmation of malign masses. However, the high variability of the organ appearance and the complex shape of both the colon wall and structures of interest make this exploration difficult. Learned visuospatial and perceptual abilities mitigate technical limitations in clinical practice by proper estimation of the intestinal depth.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!